Hi Everyone,
I hope you are all keeping well. I still believe that this $80 million CR is for GOOD reason & forward thinking by the company. So much is happening & changing quickly in the Immunology-Oncology space.
Just wanted to put this article out there for people who may have been so focused on the CR shenanigans they might have missed this:
https://www.fiercepharma.com/pharma/esmo-roche-spots-big-untouched-newly-diagnosed-lung-cancer-market-tecentriq-monotherapy
You will see the significance when you read it. Not a lot of time today to post but in NSCLC trial with PD1-VAXX in combination with Tecentriq we are embarking on now.
If no increased safety & toxicity & improved efficacy over Tecentriq as a monotherapy with PD1-VAXX, then great!
Roche supply agreement with IMU for this trial, they have the Monotherapy data for Tecentriq & PD1-VAXX (Monotherapy dose escalation Ph1). The patients who can’t tolerate chemo…Maybe some hope for them early on now.
GLTAH, happy to discuss time permitting, but I thought this was VERY significant to our PD1-VAXX trial/s.
- Forums
- ASX - By Stock
- IMU
- Media Thread
Media Thread, page-6614
-
-
- There are more pages in this discussion • 8,744 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
6.0¢ |
Change
-0.002(3.23%) |
Mkt cap ! $455.6M |
Open | High | Low | Value | Volume |
6.1¢ | 6.3¢ | 5.9¢ | $1.880M | 30.85M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 335638 | 6.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.1¢ | 2694188 | 20 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 190472 | 0.060 |
21 | 3341348 | 0.059 |
23 | 3043169 | 0.058 |
9 | 655355 | 0.057 |
9 | 1188690 | 0.056 |
Price($) | Vol. | No. |
---|---|---|
0.061 | 2700922 | 21 |
0.062 | 1843897 | 9 |
0.063 | 835953 | 8 |
0.064 | 1086952 | 8 |
0.065 | 2745000 | 7 |
Last trade - 12.07pm 04/09/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |